Tokyo, Sept. 20 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059143) titled 'Retrospective Analysis of Carbon-ion radiotherapy for Sarcoma' on Sept. 19.
Study Type:
Interventional
Study Design:
Basic Design - Single arm
Randomization - Non-randomized
Blinding - Open -no one is blinded
Control - Uncontrolled
Primary Sponsor:
Institute - National Institutes for Quantum Science and Technology (QST)
Condition:
Condition - sarcoma
Classification by malignancy - Malignancy
Genomic information - NO
Objective:
Narrative objectives1 - The objective of this study is to analyze the treatment outcomes of sarcoma cases treated with carbon-ion radiotherapy at our institution and to evaluate its safety and efficacy.
Basic objectives2 - Safety,Efficacy
Intervention:
Interventions/Control_1 - Carbon-ion raditoherpy
Eligibility:
Age-lower limit - Not applicable
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - Sarcoma cases treated with Carbon-ion raditoherpy therapy from April 1997 to July 2025.
Key exclusion criteria - Patients who have requested that their data not be used for the purpose of disclosing information about this study.
Target Size - 100
Recruitment Status:
Recruitment status - No longer recruiting
Date of protocol fixation - 2025 Year 09 Month 09 Day
Date of IRB - 2025 Year 09 Month 09 Day
Anticipated trial start date - 2025 Year 09 Month 09 Day
Last follow-up date - 2026 Year 03 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067654
Disclaimer: Curated by HT Syndication.
